PT2556834E - Tetratiomolibdato (ttm) para utilização no tratamento da lesão de isquémia-reperfusão do coração - Google Patents
Tetratiomolibdato (ttm) para utilização no tratamento da lesão de isquémia-reperfusão do coração Download PDFInfo
- Publication number
- PT2556834E PT2556834E PT121896302T PT12189630T PT2556834E PT 2556834 E PT2556834 E PT 2556834E PT 121896302 T PT121896302 T PT 121896302T PT 12189630 T PT12189630 T PT 12189630T PT 2556834 E PT2556834 E PT 2556834E
- Authority
- PT
- Portugal
- Prior art keywords
- tetrathiomolybdate
- ischemia
- heart
- treatment
- reperfusion injury
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1005394.0A GB201005394D0 (en) | 2010-03-30 | 2010-03-30 | Therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2556834E true PT2556834E (pt) | 2015-02-10 |
Family
ID=42228650
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT117166264T PT2552461E (pt) | 2010-03-30 | 2011-03-30 | Tetratiomolibdato para utilização no tratamento da lesão de isquémia-reperfusão da cabeça ou do cérebro |
| PT121896302T PT2556834E (pt) | 2010-03-30 | 2011-03-30 | Tetratiomolibdato (ttm) para utilização no tratamento da lesão de isquémia-reperfusão do coração |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT117166264T PT2552461E (pt) | 2010-03-30 | 2011-03-30 | Tetratiomolibdato para utilização no tratamento da lesão de isquémia-reperfusão da cabeça ou do cérebro |
Country Status (12)
| Country | Link |
|---|---|
| EP (3) | EP2842562B1 (pt) |
| JP (2) | JP5674917B2 (pt) |
| CN (1) | CN103096903A (pt) |
| BR (1) | BR112012024704A8 (pt) |
| DK (3) | DK2556834T3 (pt) |
| ES (3) | ES2529115T3 (pt) |
| GB (1) | GB201005394D0 (pt) |
| HU (1) | HUE024155T2 (pt) |
| PL (2) | PL2552461T3 (pt) |
| PT (2) | PT2552461E (pt) |
| SI (2) | SI2552461T1 (pt) |
| WO (1) | WO2011121354A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10478455B2 (en) | 2010-03-30 | 2019-11-19 | Ucl Business Ltd | Therapeutic use of tetrathiomolybdate |
| EP2578221A1 (en) * | 2011-10-04 | 2013-04-10 | Magnus Intellectual Property Ltd. | The therapeutic use of tetrathiomolybdate |
| US20190231815A1 (en) * | 2015-07-28 | 2019-08-01 | Insmed Incorporated | Compositions comprising copper chelators and methods of use thereof for treating vasculopathies |
| ES2874299T3 (es) | 2016-10-21 | 2021-11-04 | Ucl Business Ltd | Tetratiomolibdato de dietilamina cristalino y sus usos farmacéuticos |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6703050B1 (en) * | 1998-09-04 | 2004-03-09 | The Regents Of The University Of Michigan | Methods and compositions for the prevention or treatment of cancer |
| ATE228375T1 (de) * | 1998-09-04 | 2002-12-15 | Univ Michigan | THIOMOLYBDAT VERBUNDEN MIT MINDESTENS EINEM KOHLENHYDRAT, UND SEINE VERWENDUNG ZUR VORBEUGUNG UND BEHANDLUNG VON ERKRANKUNGEN, DIE DURCH EINE ANORMALE VASKULARISIERUNG GEKENNZEICHNET SIND, WIE Z.B. KREBS, ßFEUCHTEß MAKULADEGENERATION, RHEUMATOIDE ARTHRITIS |
| WO2003075910A1 (en) * | 2002-03-08 | 2003-09-18 | Protemix Corporation Limited | Preventing and/or treating vascular disease, cardiomyopathy and/or associated heart failure |
| US6855340B2 (en) * | 2002-05-24 | 2005-02-15 | Regents Of The University Of Michigan | Copper lowering treatment of inflammatory and fibrotic diseases |
| AU2003214725A1 (en) * | 2002-08-20 | 2004-03-11 | Protemix Corporation Limited | Preventing and/or treating cardiovascular disease and/or associated heart failure |
| US7618615B2 (en) * | 2004-08-13 | 2009-11-17 | Healthpartners Research Foundation | Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia |
| AU2007205996A1 (en) * | 2006-01-10 | 2007-07-26 | Pipex, Inc. | Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases |
| WO2008100653A2 (en) * | 2007-01-08 | 2008-08-21 | The Regents Of The University Of Michigan | Copper lowering treatment of cardiac disease |
-
2010
- 2010-03-30 GB GBGB1005394.0A patent/GB201005394D0/en not_active Ceased
-
2011
- 2011-03-30 BR BR112012024704A patent/BR112012024704A8/pt not_active Application Discontinuation
- 2011-03-30 SI SI201130380T patent/SI2552461T1/sl unknown
- 2011-03-30 DK DK12189630.2T patent/DK2556834T3/en active
- 2011-03-30 EP EP14194820.8A patent/EP2842562B1/en active Active
- 2011-03-30 DK DK14194820.8T patent/DK2842562T3/en active
- 2011-03-30 PL PL11716626T patent/PL2552461T3/pl unknown
- 2011-03-30 EP EP11716626.4A patent/EP2552461B1/en active Active
- 2011-03-30 ES ES11716626.4T patent/ES2529115T3/es active Active
- 2011-03-30 WO PCT/GB2011/050653 patent/WO2011121354A1/en active Application Filing
- 2011-03-30 PT PT117166264T patent/PT2552461E/pt unknown
- 2011-03-30 ES ES12189630.2T patent/ES2529225T3/es active Active
- 2011-03-30 JP JP2013501947A patent/JP5674917B2/ja active Active
- 2011-03-30 DK DK11716626.4T patent/DK2552461T3/en active
- 2011-03-30 PT PT121896302T patent/PT2556834E/pt unknown
- 2011-03-30 CN CN2011800168365A patent/CN103096903A/zh active Pending
- 2011-03-30 PL PL12189630T patent/PL2556834T3/pl unknown
- 2011-03-30 SI SI201130385T patent/SI2556834T1/sl unknown
- 2011-03-30 HU HUE12189630A patent/HUE024155T2/en unknown
- 2011-03-30 ES ES14194820.8T patent/ES2573809T3/es active Active
- 2011-03-30 EP EP12189630.2A patent/EP2556834B1/en active Active
-
2014
- 2014-12-22 JP JP2014258628A patent/JP6038867B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2842562B1 (en) | 2016-04-27 |
| DK2842562T3 (en) | 2016-06-06 |
| JP5674917B2 (ja) | 2015-02-25 |
| WO2011121354A1 (en) | 2011-10-06 |
| HUE024155T2 (en) | 2016-02-29 |
| EP2556834A1 (en) | 2013-02-13 |
| BR112012024704A8 (pt) | 2021-03-23 |
| JP2013523709A (ja) | 2013-06-17 |
| BR112012024704A2 (pt) | 2021-03-02 |
| EP2842562A1 (en) | 2015-03-04 |
| ES2529115T3 (es) | 2015-02-17 |
| PL2556834T3 (pl) | 2015-04-30 |
| ES2529225T3 (es) | 2015-02-18 |
| PL2552461T3 (pl) | 2015-04-30 |
| JP2015057450A (ja) | 2015-03-26 |
| GB201005394D0 (en) | 2010-05-12 |
| EP2556834B1 (en) | 2014-11-26 |
| SI2552461T1 (sl) | 2015-03-31 |
| DK2556834T3 (en) | 2015-02-09 |
| DK2552461T3 (en) | 2015-02-09 |
| PT2552461E (pt) | 2015-02-10 |
| EP2552461A1 (en) | 2013-02-06 |
| EP2552461B1 (en) | 2014-12-17 |
| CN103096903A (zh) | 2013-05-08 |
| JP6038867B2 (ja) | 2016-12-07 |
| ES2573809T3 (es) | 2016-06-10 |
| SI2556834T1 (sl) | 2015-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201207574B (en) | Phytocannabinoids in the treatment of cancer | |
| GB2495841B (en) | Phytocannabinoids for use in the treatment of breast cancer | |
| GB201115711D0 (en) | Phyto-cannabinoids for use in the treatment of cancer | |
| EP2629736A4 (en) | FABRIC TREATMENT | |
| EP2645957A4 (en) | ELIMINATION OF FAT BY NON-INVASIVE HYPERTHERMIC TREATMENT | |
| ZA201208413B (en) | Skin treatment composition | |
| EP2616094A4 (en) | TREATMENT OF BRAIN INJURIES THROUGH IMPORTS | |
| PT2872176T (pt) | Carboranilporpirinas para utilização no tratamento de cancro | |
| ZA201209452B (en) | Gold complexes for use in the treatment of cancer | |
| SI2556834T1 (sl) | Tetratiomolibdat za uporabo pri zdravljenju ishemične-reperfuzijske poškodbe srca | |
| ZA201208568B (en) | Skin treatment composition | |
| HK1214771A1 (zh) | 用於治療皮膚病的製劑 | |
| GB201718726D0 (en) | Phytocannabinoids in the treatment of cancer | |
| GB201016486D0 (en) | Compounds for the use in treatment of plants | |
| RS62399B1 (sr) | Uređaji za lečenje kožnih promena | |
| ZA201402477B (en) | Compounds for use in the treatment of alzheimer's disease | |
| HUP1000688A2 (en) | Use of trifluoro-phthalimides in the treatment of cancer | |
| GB2477546B (en) | Skin treatment apparatus | |
| GB201001659D0 (en) | Body treatment product | |
| GB2473735B (en) | Skin treatment formulation | |
| IL204097A0 (en) | Medicine for the treatment of skin cancer | |
| EP2531186A4 (en) | TREATMENT OF HAIR DRESSES | |
| GB201016836D0 (en) | Composition for skin treatment | |
| GB201016834D0 (en) | Composition for skin treatment | |
| AU2012903356A0 (en) | Improvements in Medical Treatment |